1 Market Overview of α2 Adrenergic Agonist 1.1 α2 Adrenergic Agonist Market Overview 1.1.1 α2 Adrenergic Agonist Product Scope 1.1.2 α2 Adrenergic Agonist Market Status and Outlook 1.2 Global α2 Adrenergic Agonist Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global α2 Adrenergic Agonist Market Size by Region (2016-2027) 1.4 Global α2 Adrenergic Agonist Historic Market Size by Region (2016-2021) 1.5 Global α2 Adrenergic Agonist Market Size Forecast by Region (2022-2027) 1.6 Key Regions, α2 Adrenergic Agonist Market Size (2016-2027) 1.6.1 North America α2 Adrenergic Agonist Market Size (2016-2027) 1.6.2 Europe α2 Adrenergic Agonist Market Size (2016-2027) 1.6.3 Asia-Pacific α2 Adrenergic Agonist Market Size (2016-2027) 1.6.4 Latin America α2 Adrenergic Agonist Market Size (2016-2027) 1.6.5 Middle East & Africa α2 Adrenergic Agonist Market Size (2016-2027) 2 α2 Adrenergic Agonist Market Overview by Type 2.1 Global α2 Adrenergic Agonist Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global α2 Adrenergic Agonist Historic Market Size by Type (2016-2021) 2.3 Global α2 Adrenergic Agonist Forecasted Market Size by Type (2022-2027) 2.4 α-Methyldopa 2.5 Clonidine 2.6 Brimonidine 3 α2 Adrenergic Agonist Market Overview by Application 3.1 Global α2 Adrenergic Agonist Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global α2 Adrenergic Agonist Historic Market Size by Application (2016-2021) 3.3 Global α2 Adrenergic Agonist Forecasted Market Size by Application (2022-2027) 3.4 High Blood Pressure 3.5 Migraine 3.6 Glaucoma 3.7 High Intraocular Pressure 3.8 Parkinsonism 3.9 Hepatic Coma 3.10 Others 4 α2 Adrenergic Agonist Competition Analysis by Players 4.1 Global α2 Adrenergic Agonist Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in α2 Adrenergic Agonist as of 2020) 4.3 Date of Key Players Enter into α2 Adrenergic Agonist Market 4.4 Global Top Players α2 Adrenergic Agonist Headquarters and Area Served 4.5 Key Players α2 Adrenergic Agonist Product Solution and Service 4.6 Competitive Status 4.6.1 α2 Adrenergic Agonist Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Merck 5.1.1 Merck Profile 5.1.2 Merck Main Business 5.1.3 Merck α2 Adrenergic Agonist Products, Services and Solutions 5.1.4 Merck α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.1.5 Merck Recent Developments 5.2 Icn Pharmaceuticals 5.2.1 Icn Pharmaceuticals Profile 5.2.2 Icn Pharmaceuticals Main Business 5.2.3 Icn Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.2.4 Icn Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.2.5 Icn Pharmaceuticals Recent Developments 5.3 Aa Pharma 5.5.1 Aa Pharma Profile 5.3.2 Aa Pharma Main Business 5.3.3 Aa Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.3.4 Aa Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.3.5 Pro Doc Ltée Recent Developments 5.4 Pro Doc Ltée 5.4.1 Pro Doc Ltée Profile 5.4.2 Pro Doc Ltée Main Business 5.4.3 Pro Doc Ltée α2 Adrenergic Agonist Products, Services and Solutions 5.4.4 Pro Doc Ltée α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.4.5 Pro Doc Ltée Recent Developments 5.5 Laboratoires Confab 5.5.1 Laboratoires Confab Profile 5.5.2 Laboratoires Confab Main Business 5.5.3 Laboratoires Confab α2 Adrenergic Agonist Products, Services and Solutions 5.5.4 Laboratoires Confab α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.5.5 Laboratoires Confab Recent Developments 5.6 LGM Pharma 5.6.1 LGM Pharma Profile 5.6.2 LGM Pharma Main Business 5.6.3 LGM Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.6.4 LGM Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.6.5 LGM Pharma Recent Developments 5.7 Physicians Total Care 5.7.1 Physicians Total Care Profile 5.7.2 Physicians Total Care Main Business 5.7.3 Physicians Total Care α2 Adrenergic Agonist Products, Services and Solutions 5.7.4 Physicians Total Care α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.7.5 Physicians Total Care Recent Developments 5.8 Boehringer Ingelheim Promeco 5.8.1 Boehringer Ingelheim Promeco Profile 5.8.2 Boehringer Ingelheim Promeco Main Business 5.8.3 Boehringer Ingelheim Promeco α2 Adrenergic Agonist Products, Services and Solutions 5.8.4 Boehringer Ingelheim Promeco α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.8.5 Boehringer Ingelheim Promeco Recent Developments 5.9 Sanis Health 5.9.1 Sanis Health Profile 5.9.2 Sanis Health Main Business 5.9.3 Sanis Health α2 Adrenergic Agonist Products, Services and Solutions 5.9.4 Sanis Health α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.9.5 Sanis Health Recent Developments 5.10 Pro Doc Limitee 5.10.1 Pro Doc Limitee Profile 5.10.2 Pro Doc Limitee Main Business 5.10.3 Pro Doc Limitee α2 Adrenergic Agonist Products, Services and Solutions 5.10.4 Pro Doc Limitee α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.10.5 Pro Doc Limitee Recent Developments 5.11 Vintage Pharmaceuticals 5.11.1 Vintage Pharmaceuticals Profile 5.11.2 Vintage Pharmaceuticals Main Business 5.11.3 Vintage Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.11.4 Vintage Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.11.5 Vintage Pharmaceuticals Recent Developments 5.12 Apotex 5.12.1 Apotex Profile 5.12.2 Apotex Main Business 5.12.3 Apotex α2 Adrenergic Agonist Products, Services and Solutions 5.12.4 Apotex α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.12.5 Apotex Recent Developments 5.13 Mylan Pharmaceuticals 5.13.1 Mylan Pharmaceuticals Profile 5.13.2 Mylan Pharmaceuticals Main Business 5.13.3 Mylan Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.13.4 Mylan Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.13.5 Mylan Pharmaceuticals Recent Developments 5.14 Corium International 5.14.1 Corium International Profile 5.14.2 Corium International Main Business 5.14.3 Corium International α2 Adrenergic Agonist Products, Services and Solutions 5.14.4 Corium International α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.14.5 Corium International Recent Developments 5.15 Mayne Pharma 5.15.1 Mayne Pharma Profile 5.15.2 Mayne Pharma Main Business 5.15.3 Mayne Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.15.4 Mayne Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.15.5 Mayne Pharma Recent Developments 5.16 Advanz Pharma 5.16.1 Advanz Pharma Profile 5.16.2 Advanz Pharma Main Business 5.16.3 Advanz Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.16.4 Advanz Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.16.5 Advanz Pharma Recent Developments 5.17 Vintage Pharmaceuticals 5.17.1 Vintage Pharmaceuticals Profile 5.17.2 Vintage Pharmaceuticals Main Business 5.17.3 Vintage Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.17.4 Vintage Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.17.5 Vintage Pharmaceuticals Recent Developments 5.18 Bioniche Pharma USA  5.18.1 Bioniche Pharma USA  Profile 5.18.2 Bioniche Pharma USA  Main Business 5.18.3 Bioniche Pharma USA  α2 Adrenergic Agonist Products, Services and Solutions 5.18.4 Bioniche Pharma USA  α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.18.5 Bioniche Pharma USA  Recent Developments 5.19 Xanodyne Pharmaceuticals 5.19.1 Xanodyne Pharmaceuticals Profile 5.19.2 Xanodyne Pharmaceuticals Main Business 5.19.3 Xanodyne Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.19.4 Xanodyne Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.19.5 Xanodyne Pharmaceuticals Recent Developments 5.20 Shionogi Pharma 5.20.1 Shionogi Pharma Profile 5.20.2 Shionogi Pharma Main Business 5.20.3 Shionogi Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.20.4 Shionogi Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.20.5 Shionogi Pharma Recent Developments 5.21 Tris Pharma 5.21.1 Tris Pharma Profile 5.21.2 Tris Pharma Main Business 5.21.3 Tris Pharma α2 Adrenergic Agonist Products, Services and Solutions 5.21.4 Tris Pharma α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.21.5 Tris Pharma Recent Developments 5.22 Par Pharmaceutical 5.22.1 Par Pharmaceutical Profile 5.22.2 Par Pharmaceutical Main Business 5.22.3 Par Pharmaceutical α2 Adrenergic Agonist Products, Services and Solutions 5.22.4 Par Pharmaceutical α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.22.5 Par Pharmaceutical Recent Developments 5.23 X Gen Pharmaceuticals 5.23.1 X Gen Pharmaceuticals Profile 5.23.2 X Gen Pharmaceuticals Main Business 5.23.3 X Gen Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.23.4 X Gen Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.23.5 X Gen Pharmaceuticals Recent Developments 5.24 Teva 5.24.1 Teva Profile 5.24.2 Teva Main Business 5.24.3 Teva α2 Adrenergic Agonist Products, Services and Solutions 5.24.4 Teva α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.24.5 Teva Recent Developments 5.25 PD-Rx Pharmaceuticals 5.25.1 PD-Rx Pharmaceuticals Profile 5.25.2 PD-Rx Pharmaceuticals Main Business 5.25.3 PD-Rx Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.25.4 PD-Rx Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.25.5 PD-Rx Pharmaceuticals Recent Developments 5.26 Hikma Farmaceutica 5.26.1 Hikma Farmaceutica Profile 5.26.2 Hikma Farmaceutica Main Business 5.26.3 Hikma Farmaceutica α2 Adrenergic Agonist Products, Services and Solutions 5.26.4 Hikma Farmaceutica α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.26.5 Hikma Farmaceutica Recent Developments 5.27 Cadila Pharnmaceuticals 5.27.1 Cadila Pharnmaceuticals Profile 5.27.2 Cadila Pharnmaceuticals Main Business 5.27.3 Cadila Pharnmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.27.4 Cadila Pharnmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.27.5 Cadila Pharnmaceuticals Recent Developments 5.28 Alembic Pharmaceuticals 5.28.1 Alembic Pharmaceuticals Profile 5.28.2 Alembic Pharmaceuticals Main Business 5.28.3 Alembic Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions 5.28.4 Alembic Pharmaceuticals α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.28.5 Alembic Pharmaceuticals Recent Developments 5.29 Allergan 5.29.1 Allergan Profile 5.29.2 Allergan Main Business 5.29.3 Allergan α2 Adrenergic Agonist Products, Services and Solutions 5.29.4 Allergan α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.29.5 Allergan Recent Developments 5.30 Novartis 5.30.1 Novartis Profile 5.30.2 Novartis Main Business 5.30.3 Novartis α2 Adrenergic Agonist Products, Services and Solutions 5.30.4 Novartis α2 Adrenergic Agonist Revenue (US$ Million) & (2016-2021) 5.30.5 Novartis Recent Developments 6 North America 6.1 North America α2 Adrenergic Agonist Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe α2 Adrenergic Agonist Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific α2 Adrenergic Agonist Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America α2 Adrenergic Agonist Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa α2 Adrenergic Agonist Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 α2 Adrenergic Agonist Market Dynamics 11.1 α2 Adrenergic Agonist Industry Trends 11.2 α2 Adrenergic Agonist Market Drivers 11.3 α2 Adrenergic Agonist Market Challenges 11.4 α2 Adrenergic Agonist Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market α2 Adrenergic Agonist Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global α2 Adrenergic Agonist Market Size by Region (2016-2021) & (US$ Million) Table 3. Global α2 Adrenergic Agonist Market Size Share by Region (2016-2021) Table 4. Global α2 Adrenergic Agonist Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global α2 Adrenergic Agonist Forecasted Market Size Share by Region (2022-2027) Table 6. Global α2 Adrenergic Agonist Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global α2 Adrenergic Agonist Market Size by Type (2016-2021) & (US$ Million) Table 8. Global α2 Adrenergic Agonist Revenue Market Share by Type (2016-2021) Table 9. Global α2 Adrenergic Agonist Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global α2 Adrenergic Agonist Revenue Market Share by Type (2022-2027) Table 11. Global α2 Adrenergic Agonist Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global α2 Adrenergic Agonist Market Size by Application (2016-2021) & (US$ Million) Table 13. Global α2 Adrenergic Agonist Revenue Market Share by Application (2016-2021) Table 14. Global α2 Adrenergic Agonist Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global α2 Adrenergic Agonist Revenue Market Share by Application (2022-2027) Table 16. Global α2 Adrenergic Agonist Revenue (US$ Million) by Players (2016-2021) Table 17. Global α2 Adrenergic Agonist Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in α2 Adrenergic Agonist as of 2020) Table 19. Date of Key Manufacturers Enter into α2 Adrenergic Agonist Market Table 20. Global α2 Adrenergic Agonist Top Players Headquarters and Area Served Table 21. α2 Adrenergic Agonist Product Solution and Service Table 22. Global α2 Adrenergic Agonist Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Merck Basic Information List Table 25. Merck Description and Business Overview Table 26. Merck α2 Adrenergic Agonist Products, Services and Solutions Table 27. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Merck (2016-2021) Table 28. Merck Recent Developments Table 29. Icn Pharmaceuticals Basic Information List Table 30. Icn Pharmaceuticals Description and Business Overview Table 31. Icn Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 32. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Icn Pharmaceuticals (2016-2021) Table 33. Icn Pharmaceuticals Recent Developments Table 34. Aa Pharma Basic Information List Table 35. Aa Pharma Description and Business Overview Table 36. Aa Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 37. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Aa Pharma (2016-2021) Table 38. Aa Pharma Recent Developments Table 39. Pro Doc Ltée Basic Information List Table 40. Pro Doc Ltée Description and Business Overview Table 41. Pro Doc Ltée α2 Adrenergic Agonist Products, Services and Solutions Table 42. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Pro Doc Ltée (2016-2021) Table 43. Pro Doc Ltée Recent Developments Table 44. Laboratoires Confab Basic Information List Table 45. Laboratoires Confab Description and Business Overview Table 46. Laboratoires Confab α2 Adrenergic Agonist Products, Services and Solutions Table 47. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Laboratoires Confab (2016-2021) Table 48. Laboratoires Confab Recent Developments Table 49. LGM Pharma Basic Information List Table 50. LGM Pharma Description and Business Overview Table 51. LGM Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 52. Revenue (US$ Million) in α2 Adrenergic Agonist Business of LGM Pharma (2016-2021) Table 53. LGM Pharma Recent Developments Table 54. Physicians Total Care Basic Information List Table 55. Physicians Total Care Description and Business Overview Table 56. Physicians Total Care α2 Adrenergic Agonist Products, Services and Solutions Table 57. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Physicians Total Care (2016-2021) Table 58. Physicians Total Care Recent Developments Table 59. Boehringer Ingelheim Promeco Basic Information List Table 60. Boehringer Ingelheim Promeco Description and Business Overview Table 61. Boehringer Ingelheim Promeco α2 Adrenergic Agonist Products, Services and Solutions Table 62. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Boehringer Ingelheim Promeco (2016-2021) Table 63. Boehringer Ingelheim Promeco Recent Developments Table 64. Sanis Health Basic Information List Table 65. Sanis Health Description and Business Overview Table 66. Sanis Health α2 Adrenergic Agonist Products, Services and Solutions Table 67. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Sanis Health (2016-2021) Table 68. Sanis Health Recent Developments Table 69. Pro Doc Limitee Basic Information List Table 70. Pro Doc Limitee Description and Business Overview Table 71. Pro Doc Limitee α2 Adrenergic Agonist Products, Services and Solutions Table 72. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Pro Doc Limitee (2016-2021) Table 73. Pro Doc Limitee Recent Developments Table 74. Vintage Pharmaceuticals Basic Information List Table 75. Vintage Pharmaceuticals Description and Business Overview Table 76. Vintage Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 77. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Vintage Pharmaceuticals (2016-2021) Table 78. Vintage Pharmaceuticals Recent Developments Table 79. Apotex Basic Information List Table 80. Apotex Description and Business Overview Table 81. Apotex α2 Adrenergic Agonist Products, Services and Solutions Table 82. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Apotex (2016-2021) Table 83. Apotex Recent Developments Table 84. Mylan Pharmaceuticals Basic Information List Table 85. Mylan Pharmaceuticals Description and Business Overview Table 86. Mylan Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 87. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Mylan Pharmaceuticals (2016-2021) Table 88. Mylan Pharmaceuticals Recent Developments Table 89. Corium International Basic Information List Table 90. Corium International Description and Business Overview Table 91. Corium International α2 Adrenergic Agonist Products, Services and Solutions Table 92. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Corium International (2016-2021) Table 93. Corium International Recent Developments Table 94. Mayne Pharma Basic Information List Table 95. Mayne Pharma Description and Business Overview Table 96. Mayne Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 97. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Mayne Pharma (2016-2021) Table 98. Mayne Pharma Recent Developments Table 99. Advanz Pharma Basic Information List Table 100. Advanz Pharma Description and Business Overview Table 101. Advanz Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 102. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Advanz Pharma (2016-2021) Table 103. Advanz Pharma Recent Developments Table 104. Vintage Pharmaceuticals Basic Information List Table 105. Vintage Pharmaceuticals Description and Business Overview Table 106. Vintage Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 107. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Vintage Pharmaceuticals (2016-2021) Table 108. Vintage Pharmaceuticals Recent Developments Table 109. Bioniche Pharma USA  Basic Information List Table 110. Bioniche Pharma USA  Description and Business Overview Table 111. Bioniche Pharma USA  α2 Adrenergic Agonist Products, Services and Solutions Table 112. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Bioniche Pharma USA  (2016-2021) Table 113. Bioniche Pharma USA  Recent Developments Table 114. Xanodyne Pharmaceuticals Basic Information List Table 115. Xanodyne Pharmaceuticals Description and Business Overview Table 116. Xanodyne Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 117. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Xanodyne Pharmaceuticals (2016-2021) Table 118. Xanodyne Pharmaceuticals Recent Developments Table 119. Shionogi Pharma Basic Information List Table 120. Shionogi Pharma Description and Business Overview Table 121. Shionogi Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 122. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Shionogi Pharma (2016-2021) Table 123. Shionogi Pharma Recent Developments Table 124. Tris Pharma Basic Information List Table 125. Tris Pharma Description and Business Overview Table 126. Tris Pharma α2 Adrenergic Agonist Products, Services and Solutions Table 127. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Tris Pharma (2016-2021) Table 128. Tris Pharma Recent Developments Table 129. Par Pharmaceutical Basic Information List Table 130. Par Pharmaceutical Description and Business Overview Table 131. Par Pharmaceutical α2 Adrenergic Agonist Products, Services and Solutions Table 132. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Par Pharmaceutical (2016-2021) Table 133. Par Pharmaceutical Recent Developments Table 134. X Gen Pharmaceuticals Basic Information List Table 135. X Gen Pharmaceuticals Description and Business Overview Table 136. X Gen Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 137. Revenue (US$ Million) in α2 Adrenergic Agonist Business of X Gen Pharmaceuticals (2016-2021) Table 138. X Gen Pharmaceuticals Recent Developments Table 139. Teva Basic Information List Table 140. Teva Description and Business Overview Table 141. Teva α2 Adrenergic Agonist Products, Services and Solutions Table 142. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Teva (2016-2021) Table 143. Teva Recent Developments Table 144. PD-Rx Pharmaceuticals Basic Information List Table 145. PD-Rx Pharmaceuticals Description and Business Overview Table 146. PD-Rx Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 147. Revenue (US$ Million) in α2 Adrenergic Agonist Business of PD-Rx Pharmaceuticals (2016-2021) Table 148. PD-Rx Pharmaceuticals Recent Developments Table 149. Hikma Farmaceutica Basic Information List Table 150. Hikma Farmaceutica Description and Business Overview Table 151. Hikma Farmaceutica α2 Adrenergic Agonist Products, Services and Solutions Table 152. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Hikma Farmaceutica (2016-2021) Table 153. Hikma Farmaceutica Recent Developments Table 154. Cadila Pharnmaceuticals Basic Information List Table 155. Cadila Pharnmaceuticals Description and Business Overview Table 156. Cadila Pharnmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 157. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Cadila Pharnmaceuticals (2016-2021) Table 158. Cadila Pharnmaceuticals Recent Developments Table 159. Alembic Pharmaceuticals Basic Information List Table 160. Alembic Pharmaceuticals Description and Business Overview Table 161. Alembic Pharmaceuticals α2 Adrenergic Agonist Products, Services and Solutions Table 162. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Alembic Pharmaceuticals (2016-2021) Table 163. Alembic Pharmaceuticals Recent Developments Table 164. Allergan Basic Information List Table 165. Allergan Description and Business Overview Table 166. Allergan α2 Adrenergic Agonist Products, Services and Solutions Table 167. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Allergan (2016-2021) Table 168. Allergan Recent Developments Table 169. Novartis Basic Information List Table 170. Novartis Description and Business Overview Table 171. Novartis α2 Adrenergic Agonist Products, Services and Solutions Table 172. Revenue (US$ Million) in α2 Adrenergic Agonist Business of Novartis (2016-2021) Table 173. Novartis Recent Developments Table 174. North America α2 Adrenergic Agonist Market Size by Country (2016-2021) & (US$ Million) Table 175. North America α2 Adrenergic Agonist Market Size by Country (2022-2027) & (US$ Million) Table 176. Europe α2 Adrenergic Agonist Market Size by Country (2016-2021) & (US$ Million) Table 177. Europe α2 Adrenergic Agonist Market Size by Country (2022-2027) & (US$ Million) Table 178. Asia-Pacific α2 Adrenergic Agonist Market Size by Region (2016-2021) & (US$ Million) Table 179. Asia-Pacific α2 Adrenergic Agonist Market Size by Region (2022-2027) & (US$ Million) Table 180. Asia-Pacific α2 Adrenergic Agonist Market Share by Region (2016-2021) Table 181. Asia-Pacific α2 Adrenergic Agonist Market Share by Region (2022-2027) Table 182. Latin America α2 Adrenergic Agonist Market Size by Country (2016-2021) & (US$ Million) Table 183. Latin America α2 Adrenergic Agonist Market Size by Country (2022-2027) & (US$ Million) Table 184. Middle East & Africa α2 Adrenergic Agonist Market Size by Players (2016-2021) & (US$ Million) Table 185. Middle East & Africa α2 Adrenergic Agonist Market Size by Country (2022-2027) & (US$ Million) Table 186. α2 Adrenergic Agonist Market Trends Table 187. α2 Adrenergic Agonist Market Drivers Table 188. α2 Adrenergic Agonist Market Challenges Table 189. α2 Adrenergic Agonist Market Restraints Table 190. Research Programs/Design for This Report Table 191. Key Data Information from Secondary Sources Table 192. Key Data Information from Primary Sources List of Figures Figure 1. Global α2 Adrenergic Agonist Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global α2 Adrenergic Agonist Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global α2 Adrenergic Agonist Market Share by Regions: 2021 VS 2027 Figure 4. Global α2 Adrenergic Agonist Forecasted Market Size Share by Region (2022-2027) Figure 5. North America α2 Adrenergic Agonist Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe α2 Adrenergic Agonist Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific α2 Adrenergic Agonist Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America α2 Adrenergic Agonist Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa α2 Adrenergic Agonist Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global α2 Adrenergic Agonist Market Size Share by Type in 2021 & 2027 Figure 11. α-Methyldopa Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Clonidine Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Brimonidine Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global α2 Adrenergic Agonist Market Size Share by Application in 2021 & 2027 Figure 15. High Blood Pressure Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Migraine Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Glaucoma Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. High Intraocular Pressure Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Parkinsonism Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Hepatic Coma Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. α2 Adrenergic Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Top 5 and Top 10 Players α2 Adrenergic Agonist Market Share in 2020 Figure 23. North America α2 Adrenergic Agonist Market Share by Country (2016-2027) Figure 24. United States α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 25. Canada α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 26. Germany α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 27. France α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 28. U.K. α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 29. Italy α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 30. Russia α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 31. Nordic α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 32. Rest of Europe α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 33. Asia-Pacific α2 Adrenergic Agonist Market Share by Region (2016-2027) Figure 34. China α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 35. Japan α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 36. South Korea α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 37. Southeast Asia α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 38. India α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 39. Australia α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Asia-Pacific α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 41. Latin America α2 Adrenergic Agonist Market Share by Country (2016-2027) Figure 42. Mexico α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 43. Brazil α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 44. Rest of Latin America α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 45. Middle East & Africa α2 Adrenergic Agonist Market Share by Country (2016-2027) Figure 46. Turkey α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 47. Saudi Arabia α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 48. UAE α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 49. Rest of Middle East & Africa α2 Adrenergic Agonist Market Size (2016-2027) & (US$ Million) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation

Merck Icn Pharmaceuticals Aa Pharma Pro Doc Ltée Laboratoires Confab LGM Pharma Physicians Total Care Boehringer Ingelheim Promeco Sanis Health Pro Doc Limitee Vintage Pharmaceuticals Apotex Mylan Pharmaceuticals Corium International Mayne Pharma Advanz Pharma Vintage Pharmaceuticals Bioniche Pharma USA  Xanodyne Pharmaceuticals Shionogi Pharma Tris Pharma Par Pharmaceutical X Gen Pharmaceuticals Teva PD-Rx Pharmaceuticals Hikma Farmaceutica Cadila Pharnmaceuticals Alembic Pharmaceuticals Allergan Novartis